ELECTROMED INC (ELMD) Stock Fundamental Analysis
USA - NYSEARCA:ELMD - US2854091087 - Common Stock
24.87 USD
+0.1 (+0.4%)
24.87 USD
0 (0%)
We assign a fundamental rating of 6 out of 10 to ELMD. ELMD was compared to 190 industry peers in the Health Care Equipment & Supplies industry. ELMD has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. ELMD has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year ELMD was profitable.
ELMD had a positive operating cash flow in the past year.
Of the past 5 years ELMD 4 years were profitable.
In multiple years ELMD reported negative operating cash flow during the last 5 years.
1.2 Ratios
The Return On Assets of ELMD (13.65%) is better than 95.26% of its industry peers.
The Return On Equity of ELMD (16.30%) is better than 91.58% of its industry peers.
With an excellent Return On Invested Capital value of 15.35%, ELMD belongs to the best of the industry, outperforming 95.79% of the companies in the same industry.
ELMD had an Average Return On Invested Capital over the past 3 years of 8.56%. This is in line with the industry average of 8.43%.
The last Return On Invested Capital (15.35%) for ELMD is above the 3 year average (8.56%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.65% | ||
| ROE | 16.3% | ||
| ROIC | 15.35% |
ROA(3y)7.45%
ROA(5y)8.24%
ROE(3y)8.9%
ROE(5y)9.55%
ROIC(3y)8.56%
ROIC(5y)8.69%
1.3 Margins
ELMD has a better Profit Margin (11.66%) than 87.37% of its industry peers.
In the last couple of years the Profit Margin of ELMD has grown nicely.
ELMD has a better Operating Margin (14.58%) than 84.74% of its industry peers.
In the last couple of years the Operating Margin of ELMD has grown nicely.
ELMD has a better Gross Margin (77.55%) than 91.05% of its industry peers.
ELMD's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.58% | ||
| PM (TTM) | 11.66% | ||
| GM | 77.55% |
OM growth 3Y11.05%
OM growth 5Y5.84%
PM growth 3Y12.53%
PM growth 5Y8.27%
GM growth 3Y-0.05%
GM growth 5Y0.02%
2. Health
2.1 Basic Checks
ELMD has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
ELMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
ELMD has an Altman-Z score of 17.73. This indicates that ELMD is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of ELMD (17.73) is better than 95.26% of its industry peers.
ELMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 17.73 |
ROIC/WACC1.75
WACC8.78%
2.3 Liquidity
ELMD has a Current Ratio of 5.19. This indicates that ELMD is financially healthy and has no problem in meeting its short term obligations.
ELMD has a better Current ratio (5.19) than 77.37% of its industry peers.
A Quick Ratio of 4.84 indicates that ELMD has no problem at all paying its short term obligations.
ELMD has a better Quick ratio (4.84) than 81.05% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.19 | ||
| Quick Ratio | 4.84 |
3. Growth
3.1 Past
ELMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 44.83%, which is quite impressive.
The Earnings Per Share has been growing by 17.82% on average over the past years. This is quite good.
EPS 1Y (TTM)44.83%
EPS 3YN/A
EPS 5Y17.82%
EPS Q2Q%25%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%17.27%
3.2 Future
ELMD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.33% yearly.
ELMD is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.48% yearly.
EPS Next Y17.51%
EPS Next 2Y15.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year13.69%
Revenue Next 2Y12%
Revenue Next 3Y9.48%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 29.61, ELMD can be considered very expensive at the moment.
73.16% of the companies in the same industry are more expensive than ELMD, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.41, ELMD is valued at the same level.
ELMD is valuated quite expensively with a Price/Forward Earnings ratio of 25.19.
Based on the Price/Forward Earnings ratio, ELMD is valued a bit cheaper than the industry average as 74.21% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.87. ELMD is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.61 | ||
| Fwd PE | 25.19 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ELMD indicates a somewhat cheap valuation: ELMD is cheaper than 75.79% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ELMD indicates a rather cheap valuation: ELMD is cheaper than 87.89% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.56 | ||
| EV/EBITDA | 19.27 |
4.3 Compensation for Growth
ELMD's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ELMD has an outstanding profitability rating, which may justify a higher PE ratio.
ELMD's earnings are expected to grow with 15.33% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.69
PEG (5Y)1.66
EPS Next 2Y15.33%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for ELMD!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
24.87
+0.1 (+0.4%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners50.06%
Inst Owner Change5.14%
Ins Owners7.54%
Ins Owner Change1.69%
Market Cap207.66M
Analysts82
Price Target35.7 (43.55%)
Short Float %4.27%
Short Ratio3.87
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.38%
Min EPS beat(2)2.94%
Max EPS beat(2)19.83%
EPS beat(4)4
Avg EPS beat(4)121.43%
Min EPS beat(4)2.94%
Max EPS beat(4)422.88%
EPS beat(8)6
Avg EPS beat(8)63.79%
EPS beat(12)8
Avg EPS beat(12)51.09%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.89%
Min Revenue beat(2)-2.37%
Max Revenue beat(2)4.16%
Revenue beat(4)2
Avg Revenue beat(4)1.31%
Min Revenue beat(4)-3.06%
Max Revenue beat(4)6.52%
Revenue beat(8)4
Avg Revenue beat(8)0.61%
Revenue beat(12)6
Avg Revenue beat(12)0.85%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.06%
PT rev (3m)-5.41%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.78%
EPS NY rev (1m)0%
EPS NY rev (3m)0.77%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.08%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.11%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.61 | ||
| Fwd PE | 25.19 | ||
| P/S | 3.38 | ||
| P/FCF | 17.56 | ||
| P/OCF | 17.27 | ||
| P/B | 4.73 | ||
| P/tB | 4.79 | ||
| EV/EBITDA | 19.27 |
EPS(TTM)0.84
EY3.38%
EPS(NY)0.99
Fwd EY3.97%
FCF(TTM)1.42
FCFY5.7%
OCF(TTM)1.44
OCFY5.79%
SpS7.36
BVpS5.26
TBVpS5.19
PEG (NY)1.69
PEG (5Y)1.66
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.65% | ||
| ROE | 16.3% | ||
| ROCE | 20.38% | ||
| ROIC | 15.35% | ||
| ROICexc | 23.51% | ||
| ROICexgc | 24% | ||
| OM | 14.58% | ||
| PM (TTM) | 11.66% | ||
| GM | 77.55% | ||
| FCFM | 19.25% |
ROA(3y)7.45%
ROA(5y)8.24%
ROE(3y)8.9%
ROE(5y)9.55%
ROIC(3y)8.56%
ROIC(5y)8.69%
ROICexc(3y)11.98%
ROICexc(5y)12.69%
ROICexgc(3y)12.25%
ROICexgc(5y)13.03%
ROCE(3y)11.36%
ROCE(5y)11.53%
ROICexcg growth 3Y14.49%
ROICexcg growth 5Y7.7%
ROICexc growth 3Y14.84%
ROICexc growth 5Y7.9%
OM growth 3Y11.05%
OM growth 5Y5.84%
PM growth 3Y12.53%
PM growth 5Y8.27%
GM growth 3Y-0.05%
GM growth 5Y0.02%
F-Score8
Asset Turnover1.17
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 19.8% | ||
| Cap/Sales | 0.32% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 120.96% | ||
| Profit Quality | 165.17% | ||
| Current Ratio | 5.19 | ||
| Quick Ratio | 4.84 | ||
| Altman-Z | 17.73 |
F-Score8
WACC8.78%
ROIC/WACC1.75
Cap/Depr(3y)189.91%
Cap/Depr(5y)155.01%
Cap/Sales(3y)2.65%
Cap/Sales(5y)2.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44.83%
EPS 3YN/A
EPS 5Y17.82%
EPS Q2Q%25%
EPS Next Y17.51%
EPS Next 2Y15.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%17.27%
Revenue Next Year13.69%
Revenue Next 2Y12%
Revenue Next 3Y9.48%
Revenue Next 5YN/A
EBIT growth 1Y56.01%
EBIT growth 3Y27.97%
EBIT growth 5Y18.35%
EBIT Next Year137.93%
EBIT Next 3Y45.86%
EBIT Next 5YN/A
FCF growth 1Y648.35%
FCF growth 3Y48.86%
FCF growth 5Y48.48%
OCF growth 1Y2942.32%
OCF growth 3Y43.37%
OCF growth 5Y28.48%